-
CheckOrphan NewsFlash April 30 …
4/30/2010
CheckOrphan NewsFlash for Tuesday, March 30, 2010: breaking news about rare diseases, orphan diseases, orphan drugs …
-
CheckOrphan NewsFlash April 9 …
4/09/2010
CheckOrphan NewsFlash for Friday, April 9, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and …
-
CheckOrphan NewsFlash April 1 …
4/01/2010
CheckOrphan NewsFlash for Thursday, April 1, 2010: breaking news about rare diseases, orphan diseases, orphan drugs …
NewsFlash
-
The 2013 EURORDIS Membership Meeting Will …
30 May – 1 June, 2013
Every year EURORDIS organises its Membership Meeting in a different …
-
Blood Disorders: European Hematologists …
13–16 June, 2013
Hematology is a specialty that covers everything to do with blood: its …
-
Mitral Valve Prolapse (MVP) Dysautonomia …
14–15 June, 2013
Al Davies, MD, a leading international expert in physiological …
-
World Orphan Drug Congress Asia 2013
Tuesday, 18 June, 2013
World Orphan Drug Congress Asia is a strategic 1 day conference and …
Events
Abdominal obesity metabolic syndrome
Achalasia
Clinical Impact of Peroral Endoscopic Myotomy for Esophageal Achalasia
Prospective Study on the Feasibility and Effectiveness of Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders
Personalized Peroral Endoscopic Myotomy for Achalasia
Peroral Endoscopic Remyotomy for Failed Heller Myotomy
Achalasia- familial esophageal
Acquired amegakaryocytic thrombocytopenia
Acquired angioedema
Acromegaly
A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects
Epidemiology of Acromegaly
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
Acute disseminated encephalomyelitis
Acute intermittent porphyria
Acute lymphoblastic leukemia
Acute myelocytic leukemia
Multi-centre Prospective Cohort of Childhood Leukaemia: Determinants of Health and Quality of Life of the Patients After Treatment for an Acute Leukaemia During Childhood or Adolescence - LEA
Safety and Efficacy of 72-hour and 120-hour Infusion of ON 01910.Na in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)